본문 바로가기

Biomaterials specialized company

ACE BIOPHARM

We have the solution you need

Achievement

2022

Selection as the main organization on bioindustry technology development project(Motie, 4year)
: Development of L-teanine production technology based on bioprocess
Application of 1 PCT patent and 1 patent realted cholic acid

2021

Development of Probiotic commercialization technology
Application of 2 patents related cholic acid

2020

Selection as the host organization on bioindustry core technology development project (Motie, 5year)
: Development of Cholic acid-based production technology by using bioconversion
Certification of Bio Research Institute of Acebiopharm Co., Ltd

2019

Securment and development of industrial strains for production of useful bioactive substance
Increase in the yield of the Polymo incubation process
Bio Laboratory Certification as Dongjin Pharma

2018

Develpoment and patent registration of Menaquinone-7 mass production technology
Improvement of UDCA biotransformation process-tailored substrate solubility and reaction conversion rate

2017

Scale-up of Polymo production process

2015

Development of Vitamin Production Technology from Baillus

2010

Establishment of Acebiotech

[06784] 41, Dongsan-ro 8-gil, Seocho-gu, Seoul, Republic of Korea
CEO : Min-Byoung Gyu /  TEL : +82-2-579-1056  /  FAX : +82-2-6008-3356  /  E-mail : ace@acebiopharm.com

Copyright © 2010 ABP company. All Rights Reserved.